HMGA2 and acute myeloid leukemia: The studies that followed have in recent years allowed us to consider HMGA2 as a promising molecular marker for the diagnosis of AML [172]; moreover, intervening in the balance of different signal pathways, it can be an important modulator of the main cellular mechanisms and, therefore, a potential therapeutic target in the treatment of AML [164,171,172].